NCT06165185

Brief Summary

39 healthy subjects without medication (except oral contraceptives) aged 20-70 years are recruited via advertisements or through telephone contacts with individuals that had previously participated in population-based cohort studies in Malmö. All subjects are exposed to three different intervention procedures; water and coffee loads (acutely and chronically), or no change from usual fluid intake (as a time-control), respectively in randomized order. The daily intake of coffee or water will amount to 3 L of water and 1 L of coffee, respectively for one week each. The three interventions (water, coffee and control), are separated by three weeks of normal fluid intake as a wash-out period. By testing if simple life style interventions, i.e., increased water or coffee intake, may affect vasopressin secretion, evaluated as copeptin, we will increase the knowledge as to whether such life style induced changes of copeptin may in turn lead to effects on glucose tolerance as well as on other cardiometabolic risk factors previously shown to be associated with high copeptin level. Thus, the study will lead to further understanding about vasopressin and copeptin release and how life style manipulation of the vasopressin system may influence glucose metabolism and other cardiometabolic risk factors in healthy individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2016

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2016

Completed
6.9 years until next milestone

First Submitted

Initial submission to the registry

November 22, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 11, 2023

Completed
Last Updated

December 11, 2023

Status Verified

November 1, 2023

Enrollment Period

5.1 years

First QC Date

November 22, 2023

Last Update Submit

December 6, 2023

Conditions

Keywords

copeptin, water, coffee

Outcome Measures

Primary Outcomes (1)

  • 1 week result on plasma copeptin

    Change ("∆-value") between plasma copeptin value (pmol/L) at end of control week and post-intervention values will be calculated. Significance of differences between each intervention and the time-control will be tested using paired t-test or Wilcoxon's paired rank test, depending on normality of distributions.

    7 days

Secondary Outcomes (9)

  • 1 week result on plasma glucose

    7 days

  • 1 week result on plasma insulin

    7 days

  • 1 week result on plasma glucagon

    7 days

  • 1 week result on plasma C-reactive protein

    7 days

  • 1 week result on plasma creatinine

    7 days

  • +4 more secondary outcomes

Study Arms (3)

Water

EXPERIMENTAL

At intervention day 1, during a maximum time period of 20 minutes, subjects will ingest 1 L of water (still bottled water) to map the acute water effect on the vasopressin marker copeptin (repeated blood sampling every 30 minutes for 4 hours). Day 1 then continues with the rest of the daily intake, i.e., 2 L of extra water (i.e. in addition to each subject's habitual food and fluid intake). Intervention day 2-7: 3 L extra water per day in addition to each subject's habitual food and fluid intake.

Other: Water

Coffee

EXPERIMENTAL

At intervention day 1, during a maximum time period of 20 minutes, subjects will ingest 4 dL of coffee to map the acute coffee effect on the vasopressin marker copeptin (repeated blood sampling every 30 minutes for 4 hours). Day 1 then continues with the rest of the daily intake, i.e., 6dL of extra coffee (i.e. in addition to each subject's habitual food and fluid intake). Intervention day 2-7: 1 L extra coffee per day in addition to each subject's habitual food and fluid intake.

Other: Coffee

Control

EXPERIMENTAL

At intervention day 1, during a maximum time period of 20 minutes, subjects will ingest just 10 ml of water to map the acute effect on the vasopressin marker copeptin (repeated blood sampling every 30 minutes for 4 hours). Day 1 then continues with each subject's habitual food and fluid intake. Intervention day 2-7: Each subject's habitual food and fluid intake.

Other: Control

Interventions

WaterOTHER

Please see the associated arm description

Water
CoffeeOTHER

Please see the associated arm description

Coffee
ControlOTHER

Please see the associated arm description

Control

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy subjects Age 20-70 years

You may not qualify if:

  • medication (except oral contraceptives) any type of acute illness any type of chronic illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical research unit, Internal medicine department, Skåne University Hospital in Malmö

Malmo, 20502, Sweden

Location

MeSH Terms

Conditions

Diabetes Insipidus

Interventions

WaterCoffee

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPituitary DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen CompoundsPlant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: All subjects will be exposed to three different intervention procedures; water and coffee loads (acutely and chronically), or no change from usual fluid intake (as a time-control), respectively in randomized order. The daily intake of coffee or water will amount to 3 L of water and 1 L of coffee, respectively for one week each. 3 weeks of wash-out between each intervention week.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2023

First Posted

December 11, 2023

Study Start

January 1, 2011

Primary Completion

January 31, 2016

Study Completion

December 31, 2016

Last Updated

December 11, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations